avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Vdr | mm10_v2_chr15_-_97908261_97908316 | 0.13 | 4.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_87264345 Show fit | 1.42 |
ENSMUST00000118687.1
ENSMUST00000027472.6 |
EF hand domain containing 1 |
|
chr2_-_25234227 Show fit | 1.13 |
ENSMUST00000006638.7
|
solute carrier family 34 (sodium phosphate), member 3 |
|
chr6_+_86628174 Show fit | 1.01 |
ENSMUST00000043400.6
|
aspartic peptidase, retroviral-like 1 |
|
chr3_-_88384433 Show fit | 0.97 |
ENSMUST00000076048.4
|
bone gamma carboxyglutamate protein |
|
chr15_-_72546279 Show fit | 0.91 |
ENSMUST00000044624.6
|
potassium channel, subfamily K, member 9 |
|
chr7_+_143005046 Show fit | 0.87 |
ENSMUST00000009396.6
|
tetraspanin 32 |
|
chr4_+_13743424 Show fit | 0.87 |
ENSMUST00000006761.3
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
|
chr2_-_170497141 Show fit | 0.86 |
ENSMUST00000038824.5
|
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
chr17_-_45601915 Show fit | 0.85 |
ENSMUST00000169137.1
|
predicted gene 7325 |
|
chr18_+_44104407 Show fit | 0.85 |
ENSMUST00000081271.5
|
serine peptidase inhibitor, Kazal type 11 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 1.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.2 | 1.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.9 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 0.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.9 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.8 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.0 | 0.8 | GO:0006968 | cellular defense response(GO:0006968) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 1.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.9 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.6 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 1.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.0 | 0.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.0 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.8 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.7 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 0.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |